| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From the Department of Medicine and Therapeutics (G.N.T., P.C., M.Q., K.S.W.), The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong, China; Guangdong Provincial Hospital (X.S.H.), Guangzhou, China; Kiang Wu Hospital (H.C.L.), Macau, China; and the Department of Cardiology (D.S.C.), The Royal Prince Alfred Hospital, University of Sydney, Australia.
Correspondence to Kam Sang Woo, Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong SAR. E-mail kamsangwoo{at}cuhk.edu.hk
Objective Endothelial vasodilator dysfunction and carotid intima-media thickening are useful surrogate markers of cardiovascular disease, a major cause of morbidity and mortality in type 2 diabetic patients. However, because most studies reporting the relationships between endothelial function, intima-media thickness (IMT), and hyperglycemia have compared diabetic patients with healthy controls, we report their relationship with glycemia as a continuum.
Methods and Results Brachial artery endothelial function (flow-mediated dilatation [FMD]) and carotid IMT were measured noninvasively by high-resolution ultrasound B-mode imaging in 228 apparently healthy Chinese subjects recruited from Hong Kong and Macau. FMD and IMT were significantly associated with increasing levels of glycemia, particularly in the "high normal" glycemic range, with IMT increasing and endothelium-independent dilatation decreasing linearly across the glucose tertiles, and endothelium-dependent dilatation significantly lower in the upper glucose tertile compared with the other 2 groups (P<0.01). Using multiple linear regression, fasting glucose level was identified as an independent predictor of each of these markers of vascular function (P<0.004). Additionally, other conventional cardiovascular risk factors, including obesity, blood pressure, and an adverse lipid profile, were also related to levels of glycemia (P<0.05), further contributing to impaired vascular function.
Conclusion Increasing levels of glycemia and the coexistence of other cardiovascular risk factors in apparently healthy subjects are adversely associated with arterial endothelial dysfunction and intima-media thickening.
Key Words: epidemiology atherosclerosis diabetes mellitus hypertension lipids
This article has been cited by other articles:
![]() |
J. B Keogh, G. D Brinkworth, M. Noakes, D. P Belobrajdic, J. D Buckley, and P. M Clifton Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity Am. J. Clinical Nutrition, March 1, 2008; 87(3): 567 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bouvet, E. B. de Chantemele, A.-L. Guihot, E. Vessieres, A. Bocquet, O. Dumont, A. Jardel, L. Loufrani, P. Moreau, and D. Henrion Flow-Induced Remodeling in Resistance Arteries From Obese Zucker Rats Is Associated With Endothelial Dysfunction Hypertension, July 1, 2007; 50(1): 248 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Dentali, E. Romualdi, and W. Ageno The metabolic syndrome and the risk of thrombosis Haematologica, March 1, 2007; 92(3): 297 - 299. [Full Text] [PDF] |
||||
![]() |
V. Menon, T. Greene, A. A. Pereira, X. Wang, G. J. Beck, J. W. Kusek, A. J. Collins, A. S. Levey, and M. J. Sarnak Glycosylated Hemoglobin and Mortality in Patients with Nondiabetic Chronic Kidney Disease J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3411 - 3417. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tirosh, I. Shai, D. Tekes-Manova, E. Israeli, D. Pereg, T. Shochat, I. Kochba, A. Rudich, and the Israeli Diabetes Research Group Normal Fasting Plasma Glucose Levels and Type 2 Diabetes in Young Men N. Engl. J. Med., October 6, 2005; 353(14): 1454 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Thomas, B. Tomlinson, A. S.M. Abdullah, V. T.F. Yeung, J. C.N. Chan, and K. S. Wong Association of Erectile Dysfunction With Cardiovascular Risk Factors and Increasing Existing Vascular Disease in Male Chinese Type 2 Diabetic Patients Diabetes Care, August 1, 2005; 28(8): 2051 - 2053. [Full Text] [PDF] |
||||
![]() |
B. Becker, F. Kronenberg, J. T. Kielstein, H. Haller, C. Morath, E. Ritz, D. Fliser, and for the MMKD Study Group Renal Insulin Resistance Syndrome, Adiponectin and Cardiovascular Events in Patients with Kidney Disease: The Mild and Moderate Kidney Disease Study J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1091 - 1098. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |